Cheriyan Group · Cambridge University Hospitals · University of Cambridge

Dr Joseph Cheriyan — Cambridge Clinical Research Group

Dr Joseph Cheriyan (MBChB, MA, FRCP, FESC, FACC) leads a clinical research group at Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge. The group evaluates novel and repurposed therapeutics in humans — from first-in-human safety through Phase I/II proof-of-efficacy trials — with a particular focus on cardiovascular medicine (hypertension, heart failure, acute coronary syndromes, dyslipidaemia and vascular inflammation) and respiratory medicine (COPD, COVID-19).

The group's AI, digital-biomarker and technology-enabled trial work is delivered through IGNITE — Innovative Group for Novel Interventions, Trials & Experimental Medicine, its Cambridge programme applying artificial intelligence, wearable sensors and adaptive trial methodologies to cardiovascular disease detection, monitoring and treatment.

Explore the site

This page requires JavaScript for the full interactive experience. Enable JavaScript in your browser, or follow the links above to reach individual sections.